BTS
TXMD icon

BB&T Securities’s TherapeuticsMD TXMD Stock Holding History

BB&T Securities’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-340
Closed -$78.8K – 1123
2014
Q3 		$78.8K Hold
340
– – ﹤0.01% 1021
2014
Q2 		$75.1K Hold
340
– – ﹤0.01% 974
2014
Q1 		$107K Buy
+340
New +$108K ﹤0.01% 909

Other funds holding TXMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BB&T Securities's TXMD Position: Q4 2014 in Review

BB&T Securities sold out of TherapeuticsMD (TXMD) in Q4 2014, closing a stake of 340 shares — an estimated $78.8K sold.

BB&T Securities first reported a position in TXMD in Q1 2014 and held it in 3 quarters. The position peaked at $107K in Q1 2014. 81 funds tracked by Wall St. Rank hold TXMD as of Q4 2014.

  • BB&T Securities reported no remaining TherapeuticsMD position as of Q4 2014 after selling out during the quarter.
  • BB&T Securities sold 340 TherapeuticsMD shares in Q4 2014, an estimated $78.8K.
  • BB&T Securities first reported a position in TherapeuticsMD in Q1 2014 and held it in 3 quarters.
  • BB&T Securities's TherapeuticsMD position peaked at $107K in Q1 2014.
  • 81 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2014.

Based on BB&T Securities's 13F filing for Q4 2014, filed 22 Jan 2015.